Clinic Addresses Long-Term Issues Of Childhood Cancer Treatment
3/01/2011
Although cancer in children is rare, more than 10,000 children in the United States are diagnosed with some form of the disease every year. If these children survive, studies have found that more than two-thirds develop at least one late-effect of treatment, which can include additional cancers, fertility and heart problems, limited limb function, and hearing loss...
TCD Announces First Patient Treated In Its TCD-717 Phase I Trial
3/01/2011
Traslational Cancer Drugs Pharma, S.L. ("TCD") announced that the first patient was treated on Friday the 18th of February with TCD-717 in a Phase I study performed in patients with advanced solid tumors. TCD-717 is a first-in-class, small molecule that precisely inhibits Choline Kinase Alpha, an enzyme heavily involved in the carcinogenic process...
New Peptide Could Be Effective Treatment For Triple Negative Breast Cancer
3/01/2011
A new peptide developed by researchers in Temple University's College of Science and Technology has demonstrated efficacy against triple negative breast cancer. The leptin receptor antagonist peptide, developed by researchers Laszlo Otvos and Eva Surmacz, could become an attractive option for triple negative breast cancer treatment, especially in the obese patient population...
Towards Customised Treatment Of Breast Cancer
3/01/2011
Breast cancer is the most common type of cancer in women. This extremely complex disease is attacking more and more women, and both the way it develops and its outcome can vary greatly from case to case. Women also respond differently to available treatments...
Tufts Receives Patent For Antibody Treatment Against Hemolytic Uremic Syndrome
3/01/2011
Researchers at the Cummings School of Veterinary Medicine have received U.S. patent approval for an antibody-based treatment for Hemolytic Uremic Syndrome (HUS), a potentially fatal outcome of E. coli poisoning and the leading cause of kidney failure in children. HUS is caused by the forms of E...
Promising Norwegian Treatment For Blood Clots
3/01/2011
Blood clots in the leg (deep vein thrombosis DVT) occur commonly. In one-half of the cases, the blood clot will break loose and travel through the bloodstream to the lungs which may be life-threatening. Current treatment stops the blood clot from moving, but does not prevent permanent damage to the vein. Many patients may suffer long-term swelling and pain in their legs...
Numerous public health campaigns encourage people to protect themselves from the risk of developing skin cancer, but people of all ages continue to overexpose themselves to harmful ultraviolet radiation (UVR) from the sun. Teenagers and young adults are also exposed to UVR in tanning salons...
Omega-3 Fatty Acids Tackle Cancer-Related Malnutrition
3/01/2011
A new analysis has found that supplementing the diet with fish oil may prevent muscle and weight loss that commonly occurs in cancer patients who undergo chemotherapy. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that fish oil may help combat cancer-related malnutrition...
Macmillan Comments On The Government's Warm Home Discount Consultation Response, UK
3/01/2011
Commenting on the Government's Warm Home Discount consultation response, Mike Hobday, Head of Policy at Macmillan Cancer Support, said: 'Sadly, the Government has turned its back on people with a terminal illness living in fuel poverty by failing to help them as part of the new Warm Home Discount scheme...
Bavarian Nordic A/S (OMX: BAVA) announced the initiation of a new multicenter, randomized Phase 2 study of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with PROSTVAC(R). The study will compare PROSTVAC® followed by docetaxel (chemotherapy) versus docetaxel alone...